Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2024 Apr 4;130(8):1414. doi: 10.1038/s41416-024-02667-x

Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

Anxo Rio-Vilariño 1, Aiora Cenigaonandia-Campillo 1, Ana García-Bautista 1, Pedro A Mateos-Gómez 2, Marina I Schlaepfer 1, Laura del Puerto-Nevado 1, Oscar Aguilera 1, Laura García-García 1, Carlos Galeano 3, Irene de Miguel 2, Juana Serrano-López 4, Natalia Baños 5, María Jesús Fernández-Aceñero 6, Juan Carlos Lacal 7,8, Enzo Medico 9,10, Jesús García-Foncillas 1,, Arancha Cebrián 1,
PMCID: PMC11015004  PMID: 38575733

Correction to: British Journal of Cancer 10.1038/s41416-024-02649-z, published online 11 March 2024

In this article, the funding section needs be rephrased. Currently it reads:

“This work was supported by the grant PI19/01231 funded by AEI and the European Union. A.R-V contract was funded by the program “CONTRATOS PREDOCTORALES DE FORMACIÓN EN INVESTIGACIÓN EN SALUD (PFIS)”, grant FI20/00213 from the Instituto de Salud Carlos III (ISC-III) and co-funded by the European Union associated with the project PI19/01231.”

It should be updated to:

“This work was supported by the grant PI19/01231 funded by AEI and the European Union. A.R-V contract was funded by the program “CONTRATOS PREDOCTORALES DE FORMACIÓN EN INVESTIGACIÓN EN SALUD (PFIS)”, grant FI20/00213 from the Instituto de Salud Carlos III (ISC-III) and co-funded by the European Union (ERDF/ESF, “A way to make Europe”/“Investing in your future”) associated with the project PI19/01231.

The original article has been updated.

Contributor Information

Jesús García-Foncillas, Email: jgfoncillas@fjd.es.

Arancha Cebrián, Email: arancha.cebrian@quironsalud.es.


Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES